CNBC's Steve Sedgwick discusses the accomplishments of the G8 leaders in regards to the summit's official agenda of trade, tax and transparency.» Read More
OTTAWA, June 12- Canadian Prime Minister Stephen Harper said on Wednesday his government would not be rushed into signing a free trade agreement with the European Union this week just to coincide with meetings he is holding with European leaders.
BRUSSELS, June 12- The European Union has readmitted Myanmar to a scheme allowing it to benefit from lower duties on exports, a further sign of the its rehabilitation following political reforms.
KARLSRUHE, Germany, June 12- The European Central Bank defended itself in a German court on Wednesday against suggestions that its role should be more limited, clashing with Germany's Bundesbank over its main tool in calming the euro crisis.
BRUSSELS, June 12- The European Union's chief justice official has written to the U.S. attorney general demanding an explanation for the collection of foreign nationals' data following disclosures about the "PRISM" spy programme.
The European Central Bank has room to cut interest rates further, Executive Board member Peter Praet said on Tuesday, adding that the central bank is paying "great attention" to euro zone inflation.
KARLSRUHE, Germany, June 11- The European Central Bank vigorously defended its bond-buying programme in a German courtroom on Tuesday, arguing that the scheme many credit with saving the euro from collapse was within its mandate and had not spawned unlimited risks.
*Bank of Japan refrains from measures to reduce volatility. Lower-rated euro zone debt underperformed German Bunds after the Bank of Japan announced no new measures to stem bond market volatility, further unsettling investors worried about the outlook for the U.S.
LONDON, June 11- The transformation of Turkey in less than a month from newly-minted investment grade darling to market struggler has again put the role of ratings agencies under scrutiny. Turkey won a coveted second investment grade rating from Moody's in mid-May, a decision which swept Turkish bond yields to record lows and stock markets to all-time peaks.
NEW YORK/ LONDON June 11- Phillips 66 said on Tuesday it is to sell Ireland's only refinery, another blow to Europe's ailing oil refining industry. Coryton refinery in the UK, owned by the bankrupt Petroplus group, closed last year after administrators failed to find a buyer for it.
June 11- Phillips 66 is selling its assets in Ireland, including the country's only refinery, the 71,000 barrels per day Whitegate facility in Cork, the U.S. refiner said on Tuesday. Other assets on sale include an oil and refined products storage terminal in Bantry Bay and its wholesale marketing business, the company said.
BERLIN, June 11- The European Central Bank will defend its bond-buying programme in a German court this week against charges it is really an illegal scheme to fund euro zone members through the back door.
The uneasy trio of European Commission, International Monetary Fund and European Central Bank was assembled in haste in March 2010 after Greece's public debt and deficit exploded and it was about to lose access to market funding.
*Mid-cap rivals circle, $15.50 cash bid could be enough. LONDON, June 10- Ireland's Elan has attracted the interest of a number of mid-sized drug companies and a cash offer of $15.50 per share could be enough to secure its support for a bid, a source with direct knowledge of the situation said on Monday.
DUBLIN, June 10- Irish drug firm Elan Corp Plc as expected rejected an increased offer from Royalty Pharma and on Monday said it was assessing enquiries from other interested parties.
OTTAWA, June 7- Canada and the European Union are still deadlocked over a long-delayed free trade agreement, officials said on Friday, casting more doubt on the pact as the EU shifts focus to a bigger deal with the United States.
Royalty Pharma raised its hostile bid for Irish drug firm Elan to a potential $8 billion on Friday, coming back for the third time after just 7.5 percent of shareholders accepted the last offer.
DUBLIN, June 7- Royalty Pharma raised its hostile bid for Irish drug firm Elan to a potential $8 billion on Friday, after just 7.5 percent of the target company's shareholders accepted its previous offer.
DUBLIN, June 7- Royalty Pharma's $6.4 billion bid for Irish drug firm Elan had been accepted by just 7.5 percent of the target company's shareholders before the U.S. investment firm extended the closing date by just over two weeks on Thursday.
DUBLIN/ NEW YORK, June 6- Royalty Pharma received a blow in its battle to take over Irish drug firm Elan on Thursday after a ruling on conditions attached to the U.S. company's hostile bid threatened to scupper the deal.
WASHINGTON, June 6- U.S. regulators on Thursday charged a Cyprus- based company with illegally selling financial contracts to U.S. clients, the latest crackdown on online betting after Dublin- based Intrade was forced to cease trading.